IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Inde |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Bangladesh au nom de Pays les moins avancés |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Brésil |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Afrique du Sud |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Chine |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Indonésie |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Nigéria au nom de African Group |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Égypte |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
États-Unis d'Amérique |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Japon |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Canada |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Corée, République de |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Norvège |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Union européenne |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Suisse |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Australie |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Taipei chinois |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Chili |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Brésil |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
World Health Organization (WHO) |
01/03/2017-02/03/2017 |
07/06/2017 |
|